Jane Street’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-10,200
Closed -$51.6K 11148
2025
Q3
$51.6K Buy
10,200
+100
+1% +$442 ﹤0.01% 10344
2025
Q2
$40.7K Buy
+10,100
New +$32.9K ﹤0.01% 9225
2022
Q2
Sell
-14,600
Closed -$124K 9674
2022
Q1
$124K Sell
14,600
-54,300
-79% -$382K ﹤0.01% 9344
2021
Q4
$608K Sell
68,900
-33,000
-32% -$314K ﹤0.01% 6897
2021
Q3
$1.06M Buy
101,900
+48,300
+90% +$422K ﹤0.01% 5798
2021
Q2
$563K Sell
53,600
-3,000
-5% -$29.6K ﹤0.01% 7018
2021
Q1
$582K Buy
+56,600
New +$787K ﹤0.01% 6529

Other funds holding SRTA

Jane Street's SRTA Position: Q1 2026 in Review

Jane Street reduced its Strata Critical Medical Inc (SRTA) stake by 12% in Q1 2026, selling an estimated $160K and leaving 236,231 shares worth $987K. The position accounts for ﹤0.01% of the portfolio, ranked #6519.

Jane Street first reported a position in SRTA in Q4 2020 and has held it in 19 quarters since. The position peaked at $1.3M in Q4 2025. 125 funds tracked by Wall St. Rank hold SRTA as of Q1 2026.

  • Jane Street held 236,231 shares of Strata Critical Medical Inc worth $987K as of Q1 2026.
  • Jane Street sold 33,218 Strata Critical Medical Inc shares in Q1 2026, an estimated $160K.
  • Strata Critical Medical Inc made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #6519 holding.
  • Jane Street first reported a position in Strata Critical Medical Inc in Q4 2020 and has held it in 19 quarters since.
  • Jane Street's Strata Critical Medical Inc position peaked at $1.3M in Q4 2025.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.